WEYDII1

CAT # Magaca Alaabta Sharaxaada
CPD100608 ASK1-Inhibitor-10 ASK1 Inhibitor 10 waa horjoogaha afka laga heli karo ee apoptosis signal-regulating kinase 1 (ASK1). Waxay u dooratay ASK1 oo ka sarreeya ASK2 iyo sidoo kale MEKK1, TAK-1, IKKβ, ERK1, JNK1, p38α, GSK3β, PKCθ, iyo B-RAF. Waxay joojisaa kororka streptozotocin-ku-kordhinta JNK iyo fosforyaalka p38 ee unugyada β-pancreatic ee INS-1 qaab-ku-tiirsanaan.
CPD100607 K811 K811 waa ASK1-gaar-horjooge u-dheereeya badbaadada moodeelka jiirka ee amyotrophic lateral sclerosis. K811 waxay si hufan uga hortagtay kororka unugyada ee xariiqyada gacanta ee leh muujinta sare ee ASK1 iyo HER2-unugyada GC-ga oo xad dhaaf ah. Daawaynta K811 waxay hoos u dhigtay xajmiyada burooyinka xenograft iyadoo hoos loo dhigayo calaamadaha fidinta.
CPD100606 K812 K812 waa ASK1-horjooge u gaar ah oo la helay si uu u sii dheereeyo badbaadada moodeelka jiirka ee amyotrophic lateral sclerosis.
CPD100605 MSC-2032964A MSC 2032964A waa mid awood leh oo la xushay ASK1 inhibitor (IC50 = 93 nM). Waxay xannibaysaa LPS-sababtoo ah ASK1 iyo fosforyaalka p38 ee jiirka dhaqameed ee astrocytes waxayna xakameysaa xanuunka neerfaha ee moodalka EAE. MSC 2032964A waa mid afka laga heli karo oo maskaxda gasha.
CPD100604 Selonsertib Selonsertib, oo sidoo kale loo yaqaan GS-4997, waa xannibaadaha afka ee apoptosis signal-regulating kinase 1 (ASK1), oo leh waxqabadyo ka-hortagga bararka, antineoplastic iyo ka-hortagga fibrotic-ka. GS-4997 waxay beegsataa oo ay ku xidhaa domainka catalytic kinase ee ASK1 si tartan ah oo ATP ah, si ay uga hortagto fosforyaalkeeda iyo hawlgelinteeda. GS-4997 waxay ka hortagtaa soo saarista cytokines bararka, waxay hoos u dhigtaa muujinta gen ee ku lug leh fibrosis, waxay xakameysaa apoptosis xad-dhaaf ah waxayna joojisaa kororka unugyada.
oo

Nala Soo Xidhiidh

Weydiin

Wararkii Ugu Dambeeyay

  • 7-da Isbeddel ee ugu Sarreysa ee Cilmi-baarista Dawooyinka 2018

    7-da Isbeddel ee ugu Sarreysa Cilmi-baarista Dawooyinka Waxaan...

    Iyadoo lagu jiro cadaadis sii kordhaya si loogu tartamo jawi dhaqaale iyo teknoloji oo adag, shirkadaha dawooyinka iyo bayoolojiga waa inay si joogto ah u cusbooneysiiyaan barnaamijyadooda R&D si ay horay ugu sii socdaan ...

  • ARS-1620: Horjooge cusub oo rajo leh oo loogu talagalay kansarka-KRAS-mutant

    ARS-1620: Horjooge cusub oo rajo leh oo loogu talagalay K...

    Sida laga soo xigtay cilmi-baaris lagu daabacay Cell, cilmi-baarayaashu waxay sameeyeen xannibaado gaar ah oo loogu talagalay KRASG12C oo loo yaqaan ARS-1602 taas oo keentay dib u noqoshada buro ee jiirarka. "Daraasaddani waxay ku siinaysaa caddayn vivo ah in KRAS mutant uu noqon karo ...

  • AstraZeneca waxay heshaa kor u qaadida sharciyeynta ee daawooyinka kansarka

    AstraZeneca waxay heshay kor u qaadida sharciyeynta ee...

    AstraZeneca waxay heshay labanlaab kor u qaadis ah faylalka Oncology Talaadadii, ka dib markii sharciyeeyayaasha Mareykanka iyo Yurub ay aqbaleen soo gudbinta sharciyeynta dawooyinkeeda, tallaabada ugu horreysa ee lagu guuleysto oggolaanshaha daawooyinkan. ...

WhatsApp Online chat!